Article

Orange Book Listing Opportunities for Drug-Device Combinations

Authors

Authors: Terry G. Mahn, Michael A. Siem, and Elizabeth M. Flanagan

 

Read the full article (PDF).

 

With many blockbuster drugs coming off patent in the next several years, Branded Pharmaceutical Companies are looking for more and more ways to protect their products. Increasingly, such companies are listing patents covering medical devices integral to drug delivery in the Orange Book as a means to do so.  As described below this practice appears to be proper and presents an intriguing strategy to protect market share.